Halozyme Therapeutics, Inc.HALONASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank100
3Y CAGR+38.3%
5Y CAGR+54.4%
Year-over-Year Change
Free cash flow yield
3Y CAGR
+38.3%/yr
Annual compound
5Y CAGR
+54.4%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
8.8x
Strong expansion
Streak
3 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 7.99% | +3.5% |
| 2024 | 7.72% | +0.9% |
| 2023 | 7.66% | +153.3% |
| 2022 | 3.02% | -42.6% |
| 2021 | 5.27% | +478.9% |
| 2020 | 0.91% | +126.0% |
| 2019 | -3.50% | -35.5% |
| 2018 | -2.58% | -153.8% |
| 2017 | 4.80% | +212.7% |
| 2016 | -4.26% | - |